Satender Pal Singh

Dr. Satender Pal Singh

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2024 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
SSSatender Pal Singh
Satender Pal Singh
TMTushar Madke
Tushar Madke
PCPhool Chand
Phool Chand

15 February 2024 in Liver International
Verified
Journal Article
Closed access
MYManisha Yadav
Manisha Yadav
RMRakhi Maiwal
Rakhi Maiwal
VBVinay Kumar Br
Vinay Kumar Br
GTGaurav Tripathi
Gaurav Tripathi
NSNeha Sharma
Neha Sharma
SSShiv Kumar Sarin
Shiv Kumar Sarin

29 February 2024 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
ACAshok Choudhury
Ashok Choudhury
SSSatender Pal Singh
Satender Pal Singh
ADAkhil Desmukh
Akhil Desmukh
BSBishnupriya Sahoo
Bishnupriya Sahoo
MEMohammed Eslam
Mohammed Eslam

23 May 2023 in Liver Transplantation
Verified
Journal Article
Closed access
SSSatender Pal Singh
Satender Pal Singh
RMRakhi Maiwall
Rakhi Maiwall
An abstract is unavailable. This article is available as a PDF only.

8 February 2025 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
SSSatender Pal Singh
Satender Pal Singh
KKKaran Kumar
Karan Kumar
AKAnand Kulkarni
Anand Kulkarni
VAVinod Arora
Vinod Arora
ACAshok Choudhury
Ashok Choudhury
SSShiv Kumar Sarin
Shiv Kumar Sarin

26 June 2023 in Indian Journal of Radiology and Imaging
Verified
Journal Article
Open access
PDF file
AMAmar Mukund
Amar Mukund
TYTanya Yadav
Tanya Yadav
SSSatender Pal Singh
Satender Pal Singh
SSSaggere Muralikrishna Shasthry
Saggere Muralikrishna Shasthry
RMRakhi Maiwall
Rakhi Maiwall
SSShiv Kumar Sarin
Shiv Kumar Sarin
Objectives Direct intrahepatic portosystemic shunt (DIPS) stent placement is an effective treatment for patients with Budd-Chiari syndrome (BCS); however, thrombotic occlusion of DIPS stent remains a cause of concern. The purpose of this study is to describe a novel technique of balloon-occluded-thrombolysis (BOT) for occluded DIPS stent, and compare it with the conventional catheter-directed-thrombolysis (CDT). Methods In this retrospective study, the hospital database was searched for BCS patients who underwent DIPS revision for thrombotic stent occlusion between January 2015 and February 2021. Patients were divided into CDT group and BOT group. The groups were compared for technical success, total dose of thrombolytic agent administered, duration of hospital stay, and primary assisted stent patency rates at 1- and 6-month follow-up. Results CDT was performed in 12 patients, whereas 21 patients underwent BOT. Complete recanalization was achieved in 66.7% (8 of 12) patients of CDT group as compared to 81% (17 of 21) patients of BOT group (nonsignificant difference, p = 0.420). BOT group had a short hospital stay (1.8 ± 0.7 vs. 3.5 ± 1.0 days) and required less dose of thrombolytic agent ([2.2 ± 0.4]x105 IU versus [8.3 ± 2.9]x105 IU of urokinase) as compared to the CDT group and both differences were statistically significant (p < 0.001). Further, 6-month patency rate was higher in BOT group as compared to CDT group (p = 0.024). Conclusion The novel BOT technique of DIPS revision allows longer contact time of thrombolytic agent with the thrombi within the occluded stent. This helps in achieving fast recanalization of thrombosed DIPS stent with a significantly less dose of thrombolytic agent required, thus reducing the risk of systemic complications associated with thrombolytic administration. A.M. was involved in conceptualization, methodology, reviewing, editing and finalizing the manuscript. T.Y. helped in data curation, data analysis, preparation of first draft of the manuscript. S.P.S. helped in data Curation and reviewing the manuscript. S.M.S. contributed to patient enrolling, clinical management, and methodology. R.M. helped in patient enrolling, clinical management, and data analysis. Y.P. helped in imaging evaluation of patients and reviewing the manuscript. S.K.S. was involved in supervising the research, reviewing, and editing to reach the final version of manuscript. Clinical trials.gov ID: NCT05117684. Approval for the study was obtained from institutional review board (IEC/2021/86/MA15). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study has obtained IRB approval from (IEC/2021/86/MA15) and the need for informed consent was waived. Consent for publication was obtained for every individual person's data included in the study. Article published online: 26 June 2023 © 2023. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India